Sunday, July 22, 2018
 
 
Company News: Page (1) of 1 - 05/08/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Mallinckrodt plc Reports First Quarter 2018 Results
-- Net sales of $572.6 million driven by strong hospital products performance ---- GAAP¹ diluted loss per share from continuing operations of $0.50, adjusted diluted earnings per share of $1.31 ---- C...
(May 08, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Manufacturing,Office Equipment,Sales,Distribution,Manufacturing/Production,Manufacturing,Sales & Marketing,Internet,Business Issues,Law & Regulations,Management,Finance/Accounting,Sales,Finance/Accounting,Sales,Pro AV,Management,Presentors,Business,Law,Standards/Initiatives,Business Issues,Presentation,Channel/Distribution,Events,
Related Sites: Digital Producer ,   Presentation Master ,   DMN Newswire ,   itbusinessnet.com ,   IBN - Business ,   IBN - Internet ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: DMN Newsletter ,   CMN Newsletter ,   KNews Newsletter ,   Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research

    Cancer
  • BeiGene Announces Plan to Pursue Accelerated Approval in the U.S. of BTK Inhibitor Zanubrutinib in Waldenström Macroglobulinemia (WM)
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
  • DR. JOON SONG - A CERTIFIED AND TOP NOMINATED GYNECOLOGIST AND ROBOTIC SURGEON
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines